Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 0.0674M
March 31, 2026 0.0762M
December 31, 2025 0.0862M
September 30, 2025 0.1028M
June 30, 2025 0.1022M
March 31, 2025 0.1198M
December 31, 2024 0.073M
September 30, 2024 0.0002M
June 30, 2024 0.0042M
March 31, 2024 0.00
December 31, 2023 0.0793M
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.005M
December 31, 2022 0.0939M
September 30, 2022 0.0271M
June 30, 2022 0.0658M
March 31, 2022 0.0754M
December 31, 2021 0.1077M
September 30, 2021 0.3204M
June 30, 2021 0.3344M
March 31, 2021
December 31, 2020 0.3758M
September 30, 2020 0.4036M
June 30, 2020 0.4482M
Date Value
March 31, 2020 0.5057M
December 31, 2019 0.5732M
September 30, 2019 0.5661M
June 30, 2019 0.6275M
March 31, 2019 0.7274M
December 31, 2018 0.7814M
September 30, 2018 0.9708M
June 30, 2018 0.9959M
March 31, 2018 0.1557M
December 31, 2017 0.1865M
September 30, 2017 0.149M
June 30, 2017 0.2056M
March 31, 2017 0.2602M
December 31, 2016 0.0996M
September 30, 2016 0.0453M
June 30, 2016 0.1797M
March 31, 2016 0.4032M
December 31, 2015 0.6436M
September 30, 2015 0.922M
June 30, 2015 1.183M
March 31, 2015 1.419M
December 31, 2014 1.662M
September 30, 2014 0.1307M
June 30, 2014 0.2275M
March 31, 2014 0.0172M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M
Veru, Inc. 37.03M
Johnson & Johnson 197.42B
Eli Lilly & Co. 142.28B

Total Assets (Quarterly) Related Metrics